Population
Patients with chronic kidney disease (CKD)
Design
Review
Authors
Loading...
Emphasizes closing treatment gaps in CKD despite amplified benefits; leaves open implementation trials to guide uptake.
This review highlights that chronic kidney disease is an independent cardiovascular risk state and emphasizes the under-utilization and heightened benefit of cardioprotective therapies in this population.
Peter A. McCullough (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: